Respiratory Syncytial Virus Diagnostics Market : Industry Analysis, Share, Segmentation, Price Trends, Regional Analysis and Forecast 2032
The Global Respiratory Syncytial Virus (RSV) diagnostics market size was USD 923.0 Million in 2022 and is expected to register a steady revenue CAGR of 10.9% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of respiratory infections and demand for Point-Of-Care (POC) devices and increasing neonatal population are major factors driving market revenue growth. RSV is a mild infection affecting the upper respiratory tract of young children. The common symptoms of RSV include cough, sore throat, wheezing, and runny nose.
Upper Respiratory Infections (URIs) is the most frequent disorder. According to the National Health Portal of India, 41,996,260 instances of respiratory infections and 3,740 deaths were documented in India. India accounts for 18% of the world's population, with Severe Acute Respiratory Infection (SARI) being one of the leading causes of death. In addition, increasing investments into healthcare infrastructure and product launches for syncytial virus diagnostic products by leading companies is another key factor driving revenue growth of the market. On 2 November 2022, QuantuMDx Group Limited, based in the UK, and A.Menarini Diagnostics S.r.I. (Menarini) signed an exclusive distribution agreement for QuantuMDx's Q-POCTM technology in the UK and France. Menarini is able to market, distribute, and service Q-POCTM, QuantuMDx's SARS-CoV-2 assay.Request
Free Sample Copy (To Understand the Complete Structure of this Report [Summary
+ TOC]) @ https://www.emergenresearch.com/request-sample/1989
However, low detection power of immunoassay is a major
factor, which could restrain market revenue growth. According to National
Center for Biotechnology Information (NCBI), immunoassays take advantage of the
highly specific interaction between antibodies and antigens to offer a critical
tool for detecting biomolecules in low quantities. Furthermore, product recalls
by leading companies and federal government agencies is another factor, which
could restrain market revenue growth.
Key Highlights from the Report
- The
molecular diagnostics segment is expected to account for largest revenue
share in the global RSV diagnostics market during the forecast period.
This is due to technological advancements and development in molecular
diagnostics and inclusion of new technologies and extremely precise tests
into clinical testing methods. The most widely used techniques for
RSV molecular diagnostics are Reverse Transcriptase Polymerase Chain
Reaction (RT-PCR) and multiplexed nucleic acid amplification. As a result,
major companies are developing and manufacturing molecular diagnostics.
- The
Rapid Antigen Diagnostic Tests (RADTs) segment is expected to register
steadily fast revenue growth rate in the global RSV diagnostics market
during the forecast period. RADT for RSV is widely employed in clinical
laboratories, which have the potential benefits of Point-Of-Care (POC)
testing. Microbiologic diagnosis of RSV has been determined by moderate to
complex laboratory procedures (cell culture, nucleic acid amplification,
and immunofluorescence assays)
- The
North America accounted for largest revenue share in the global RSV
diagnostics market in 2022 due to rising prevalence of RSV. RSV attacks
the lungs and breathing passageways, and nearly all children in the U.S.
are infected with RSV by the age of two. RSV infection symptoms are
usually mild and dissipate within a week in healthy persons. In addition,
RSV can cause serious injuries or fatalities in vulnerable persons, such
as neonatal and very young infants, children with persistent lung
conditions or congenital heart disease, and people over the age of 65. RSV
infection is predicted to cause roughly 14,000 fatalities and 58,000
hospitalizations among children under the age of five in the U.S. each
year.
Additionally, the report covers the analysis
of the key players in the industry with a special focus on their global
position, financial status, and their recent developments. Porter’s Five Forces
Analysis and SWOT analysis have been covered by the report to provide relevant
data on the competitive landscape.
Detailed
Regional Analysis covers:
·
North America (U.S.,
Canada)
·
Europe (U.K., Italy,
Germany, France, Rest of EU)
·
Asia-Pacific (India,
Japan, China, South Korea, Australia, Rest of APAC)
·
Latin America (Chile,
Brazil, Argentina, Rest of Latin America)
·
Middle East &
Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Emergen
Research is Offering Limited Time Discount (Grab a Copy at Discounted Price
Now) @ https://www.emergenresearch.com/request-discount/1989
Market Overview:
The
report bifurcates the Respiratory Syncytial Virus Diagnostics market on the
basis of different product types, applications, end-user industries, and key
regions of the world where the market has already established its presence. The
report accurately offers insights into the supply-demand ratio and production
and consumption volume of each segment.
Emergen Research has segmented global RSV diagnostics
market on the basis of product, end-use, and region:
- Product
Outlook (Revenue, USD Million; 2019-2032)
- Rapid
Antigen Diagnostic Test (RADTs)
- Direct
Fluorescent Antibody (DFA) Method
- Molecular
Diagnostics
- Chromatographic
Immunoassay
- Gel
Microdroplets
- Others
- End-use
Outlook (Revenue, USD Million; 2019-2032)
- Hospitals
and clinics
- Laboratory
- Homecare
The section on the
competitive landscape offers valuable and actionable insights related to the
business sphere of the Respiratory Syncytial Virus Diagnostics market, covering
extensive profiling of the key market players. The report offers information
about market share, product portfolio, pricing analysis, and strategic
alliances such as mergers and acquisitions, joint ventures, collaborations,
partnerships, product launches and brand promotions, among others. The report
also discusses the initiatives taken by the key companies to combat the impact
of the COVID-19 pandemic.
Key Companies Profiled in the Report are: Thermo Fisher Scientific
Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Quidel
Corporation., Coris BioConcept, Quest Diagnostics Incorporated., Novartis AG,
Merck KGaA, Coris BioConcept, and Abbott
Browse
Full Report Description + Research Methodology + Table of Content +
Infographics @ https://www.emergenresearch.com/industry-report/respiratory-syncytial-virus-diagnostics-market
Highlights
of Table of Contents (TOC):
· Overview
of Global Respiratory Syncytial Virus Diagnostics Market
· Competitive
analysis of the Respiratory Syncytial Virus Diagnostics market
· Regional
analysis of Global Respiratory Syncytial Virus Diagnostics market production
and revenue
· Regional
analysis of Global Respiratory Syncytial Virus Diagnostics market supply,
consumption, and export & import
· Type-based
market analysis of global Respiratory Syncytial Virus Diagnostics production,
revenue, and price trends
· Application-based
analysis of the global Respiratory Syncytial Virus Diagnostics market
· Manufacturer
profiles, manufacturing cost, and upstream and downstream analysis of global Respiratory
Syncytial Virus Diagnostics market
· Global
Respiratory Syncytial Virus Diagnostics market forecast (2023-2032)
· Conclusion
of the research report
· Appendix
Thank you for reading our report. Please get in touch with us if you
have any query regarding the report or its customization. Our team will ensure
the report is best suited to your needs.
Latest Published Reports by Emergen Research:
automotive
regenerative braking systems market: https://www.emergenresearch.com/industry-report/automotive-regenerative-braking-systems-market
synthetic food
market: https://www.emergenresearch.com/industry-report/synthetic-food-market
5g networks
market: https://www.emergenresearch.com/industry-report/5g-networks-market
ai-based
sensors market: https://www.emergenresearch.com/industry-report/ai-based-sensors-market
biosensors
market: https://www.emergenresearch.com/industry-report/biosensors-market
About Us:
Emergen Research is a market research and consulting company that
provides syndicated research reports, customized research reports, and
consulting services. Our solutions purely focus on your purpose to locate,
target, and analyse consumer behavior shifts across demographics, across
industries, and help clients make smarter business decisions. We offer market
intelligence studies ensuring relevant and fact-based research across multiple
industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
We consistently update our research offerings to ensure our clients are aware
of the latest trends existent in the market. Emergen Research has a strong base
of experienced analysts from varied areas of expertise. Our industry experience
and ability to develop a concrete solution to any research problems provides
our clients with the ability to secure an edge over their respective
competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Trending Report: craniomaxillofacial devices
market | autonomous vehicle market
Trending Title: clinical decision support systems
market | cobots market
Comments
Post a Comment